Citadel Advisors LLC 13D and 13G filings for Aclaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:14 pm Sale | 2024-09-30 | 13G | Aclaris Therapeutics, Inc. ACRS | Citadel Advisors LLC | 368,067 0.500% | -5,038,022 (-93.19%) | Filing |
| 2024-02-14 4:58 pm Purchase | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | Citadel Advisors LLC | 5,406,089 7.600% | 1,819,325 (+50.72%) | Filing |
| 2023-09-05 4:14 pm Purchase | 2023-08-25 | 13G | Aclaris Therapeutics, Inc. ACRS | Citadel Advisors LLC | 3,586,764 5.100% | 3,586,764 (New Position) | Filing |